UBS’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$13K Sell
5,250
-326
-6% -$807 ﹤0.01% 5651
2014
Q2
$14K Sell
5,576
-12,962
-70% -$32.5K ﹤0.01% 5518
2014
Q1
$49K Buy
18,538
+15,432
+497% +$40.8K ﹤0.01% 4588
2013
Q4
$9K Sell
3,106
-2,191
-41% -$6.35K ﹤0.01% 5723
2013
Q3
$16K Buy
+5,297
New +$16K ﹤0.01% 5199
2013
Q2
Hold
0
6226